Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Saved in:
| Title: | Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. |
|---|---|
| Authors: | Yang S; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China., Zhang X; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China., Gale RP; Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK., Du X; Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China., Chen CY; Department of Haematology, Qilu Hospital, Shandong University, Jinan, China., Weng JY; Department of Haematology, Guangdong Provincial People's Hospital, Guangzhou, China., Huang J; Department of Haematology, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, China.; Department of Haematology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Li F; Center of Haematology, The First Affiliated Hospital of Nanchang University, Nanchang, China., Zeng Y; The First Affiliated Hospital of Kunming Medical University, Kunming, China., Xiao Z; The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Hu JD; Fujian Medical University Union Hospital, Fuzhou, China., Yang LJ; Xi'an International Medical Center Hospital, Xi'an, China., Liu ZG; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China., Li GH; Xi'an International Medical Center Hospital, Xi'an, China., Sun XL; Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China., Yang W; Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China., Feng R; Department of Hematology, Beijing Hospital, Beijing, China., Han YQ; The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China., Jing Y; Department of Hematology, Chinese People's Liberation Army General Hospital, Beijing, China., Xu N; Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Liu XL; Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Liu ZF; Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China., Wang XD; Department of Haematology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.; Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, China.; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China., Wu SX; The Second Affiliated Hospital of Fujian Medical University, Fujian, China., Liang R; Department of Haematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Zhang YL; Department of Haematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China., Yang YF; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China., Zhu HL; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China., Pan L; Department of Haematology, Institute of Haematology, West China Hospital, Sichuan University, Chengdu, China., Meng L; Department of Haematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zhao YH; The First Affiliated Hospital, Harbin Medical University, Harbin, China., Yi H; Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China., Liu YL; Hematology Department, The General Hospital of Western Theater Command, PLA, Chengdu, China., Zhang WH; First Hospital of Shangxi Medical University, Shangxi, China., Zheng YJ; First Hospital of Shangxi Medical University, Shangxi, China., Zhou ZP; Dept. of Hematology, The Second Hospital Affiliated to Kunming medical university, Kunming, China., Chen SN; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China., Qiu HY; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China., Li WM; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Jia ZL; Department of Hematology, The First Affiliated Hospital of Dalian Medical University, Dalian, China., Bai YL; Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China., Lin LE; Hainan General Hospital, Hainan, China., Liu BC; National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Liu CS; First Hospital of Jilin University, Jilin, China., Luo JM; The Second Hospital of Hebei Medical University, Shijiazhuang, China., Meng JX; Anyang District Hospital, Puyang, China., Sun ZQ; Shenzhen Hospital of Southern Medical University, Shenzhen, China., Zhang YQ; Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China., Huang XJ; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.; Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China.; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.; Research Unit of Key Technique for Diagnosis and Treatments of Haematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China., Jiang Q; National Clinical Research Center for Haematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Haematology, Beijing, China.; Collaborative Innovation Center of Haematology, Soochow University, Suzhou, China. |
| Source: | American journal of hematology [Am J Hematol] 2023 Jul; Vol. 98 (7), pp. E183-E186. Date of Electronic Publication: 2023 May 02. |
| Publication Type: | Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.26943 |
